American Healthcare REIT Appoints Jeffrey T. Hanson as Interim Chief Executive Officer and President; Details of New Compensation Package Disclosed

Key Highlights from the 8-K/A Filing

• Leadership Change: Jeffrey T. Hanson, current Chairman of the Board and former CEO (2015-2021), has been appointed as Interim Chief Executive Officer and President, effective February 3, 2026, while CEO Danny Prosky is on a leave of absence.
• Comprehensive Compensation Package: Mr. Hanson’s new compensation arrangement as Interim CEO includes a significant base salary, annual bonus opportunity, and substantial equity awards.
• Potential Share Price Impact: The appointment of a high-profile executive with a robust incentive package and the temporary absence of the prior CEO may be viewed as significant by investors and could impact share price volatility.

In-Depth Details for Investors

1. Leadership Transition and Management Stability

American Healthcare REIT, Inc. (NYSE: AHR) announced via an amended 8-K/A that, as of February 3, 2026, Jeffrey T. Hanson has stepped in as Interim Chief Executive Officer and President. This leadership transition follows the temporary leave of absence taken by Danny Prosky, the company’s previous CEO and President. Hanson brings considerable experience, having previously served as CEO from 2015 to 2021 and currently serving as Chairman of the Board. He will retain his role as Chairman during his tenure as Interim CEO.

2. Compensation Arrangements for Jeffrey T. Hanson

• Base Salary:
  • Hanson will receive a base salary of \$70,666.67 per month (equivalent to approximately \$848,000 annually, subject to standard payroll withholdings).
• Annual Bonus:
  • Eligible for an annual cash performance bonus, with the actual amount determined by the Board based on achievement of performance objectives.
  • Performance goals for the 2026 bonus will be weighted 70% on corporate performance (aligned with other named executive officers) and 30% on individual performance.
  • The bonus for 2026 will be paid on or before March 15, 2027, following final determination by the Board.
• Equity Awards:
  • Time-Based Restricted Stock Units (RSUs): On or before March 31, 2026, Hanson will be awarded RSUs with a grant date value of not less than \$2,027,075. The number of units is calculated based on the closing stock price at the time of grant, subject to pro-rata adjustment for the period served as Interim CEO in 2026.
  • Performance-Based Restricted Stock Units (PSUs): Hanson will also receive PSUs valued at not less than \$2,027,075, likewise based on the closing stock price and the service period as Interim CEO. The PSU performance goals will mirror those set for other executive officers.
  • Both RSUs and PSUs will be governed by the company’s Second Amended and Restated 2015 Incentive Plan, with vesting occurring upon the earlier of March 15, 2027, or within 30 days following the expiration of his interim service.
• No Additional Board Compensation: Hanson will not receive additional compensation for his continued service as Chairman of the Board but will continue to vest in any prior equity awards.

3. Additional Terms and Shareholder Considerations

• At-Will Employment: Hanson’s employment is at-will, allowing either party to terminate the arrangement at any time.
• Confidentiality and Compliance: He is subject to all company policies, including strict confidentiality regarding company information.
• Potential for Share Price Sensitivity: Leadership transitions, particularly involving the CEO, can be viewed as significant by shareholders and may introduce uncertainty or speculation regarding company direction, operational continuity, or strategic priorities. The robust incentive package, especially the large equity grants, also aligns Mr. Hanson’s interests with those of shareholders, but may be interpreted by the market as a signal of the Board’s desire to retain and motivate top executive talent during this period of transition.

4. Securities Information

• Ticker Symbol: AHR
• Exchange: New York Stock Exchange (NYSE)
• Security: Common Stock, \$0.01 par value per share

Conclusion

The appointment of Jeffrey T. Hanson as Interim CEO and President, combined with the disclosure of a substantial compensation and equity package, represents a major development for American Healthcare REIT. This transition signals a strategic move by the Board to ensure experienced leadership during a period of uncertainty. Investors should closely monitor further updates regarding Danny Prosky’s status and any business developments resulting from this executive change, as they may have a material impact on the company’s operations and share price.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a qualified financial advisor before making investment decisions. The information in this article is based on filings with the SEC and may be subject to change or updates.

View American Healthcare REIT, Inc. Historical chart here